A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but ...
A novel bipolar conduction system pacing implantable cardioverter defibrillator lead demonstrated short-term safety and ...
Background Conduction system pacing (CSP) has emerged as an alternative to right ventricular pacing (RVP) for ...
BERLIN, Germany—Conduction-system pacing (CSP), including His-bundle and left bundle branch area pacing (LBBAP), has emerged as an alternative to biventricular pacing for patients treated with cardiac ...
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
Medtronic has secured FDA approval for its OmniaSecure defibrillation lead to be used in conduction system pacing, the first device cleared for left bundle branch area placement. The small, lumenless ...
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
NEW ORLEANS -- Among patients with heart failure, conduction system pacing-guided cardiac resynchronization therapy was associated with improvements in left ventricular ejection fraction (LVEF) ...
Conduction-system pacing (CSP) was put to the test in two randomized trials of patients requiring cardiac resynchronization therapy (CRT) for left bundle branch block (LBBB)—the HeartSync-LBBP and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results